IMMUNEXT, INC.

Basic Information

1 MEDICAL CENTER DRIVE
LEBANON, NH, 03756-1000

http://www.immunext.com

Company Profile

n/a

Additional Details

Field Value
DUNS: 967719241
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 12


  1. Validation of a Negative Regulator as a Novel Therapy for Autoimmune Disease

    Amount: $1,949,257.00

    DESCRIPTION provided by applicant Systemic lupus erythematosus SLE is a devastating autoimmune disease that most commonly affects women in their child bearing years SLE attacks multiple organ sy ...

    STTR Phase II 2014 Department of Health and Human Services National Institutes of Health
  2. Safe And Effective Anti-CD154 Antibodies For Therapeutic Intervention

    Amount: $290,914.00

    DESCRIPTION (provided by applicant): There is compelling evidence that ?CD154 treatment has great potential in autoimmunity and graft rejection. Autoimmunity. Clinical efficacy of ?CD154 t ...

    STTR Phase I 2013 Department of Health and Human Services
  3. Safe and effective anti CD154 antibodies for therapeutic intervention

    Amount: $2,960,698.00

    DESCRIPTION (provided by applicant): In both animal proof of concept studies and preliminary clinical trials, there is ample data demonstrating the potential therapeutic benefits o CD154 blockade for ...

    SBIR Phase II 2013 Department of Health and Human Services
  4. Safe and effective anti CD154 antibodies for therapeutic intervention

    Amount: $2,960,698.00

    DESCRIPTION provided by applicant In both animal proof of concept studies and preliminary clinical trials there is ample data demonstrating the potential therapeutic benefits o CD blockade for ...

    SBIR Phase II 2013 Department of Health and Human Services National Institutes of Health
  5. Validation of a Negative Regulator as a Novel Therapy for Autoimmune Disease

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): The immune system depends upon an exquisite balance between positive and negative signals to maintain proper function. However, disruptions of this balance can lea ...

    STTR Phase I 2012 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government